Natural Capsules Ltd.
NSE: NATCAPSUQ BSE: NATCAPSUQ
Prev Close
157.09
Open Price
163
Volume
3,007
Today Low / High
152 / 163
52 WK Low / High
152 / 296
Range
148 - 163
Prev Close
156.45
Open Price
156.05
Volume
53
Today Low / High
156 / 159
52 WK Low / High
152 / 296.4
Range
149 - 165
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 155.45 (target range: 148 - 163), reflecting a change of -1.64 (-1.04399%). On the BSE, it is listed at 157 (target range: 149 - 165), showing a change of 0.55 (0.35155%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Natural Capsules Ltd. Graph
Natural Capsules Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Natural Capsules Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 155.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 157.00 | 158.57 | 142.71 - 174.43 |
| 160.14 | 128.11 - 192.17 | ||
| 161.71 | 113.20 - 210.22 | ||
| Bearish Scenario | 157.00 | 155.43 | 139.89 - 170.97 |
| 153.86 | 123.09 - 184.63 | ||
| 152.29 | 106.60 - 197.98 |
Overview of Natural Capsules Ltd.
ISIN
INE936B01015
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
5,355
Market Cap
1,607,532,389
Last Dividend
0
Official Website
IPO Date
2025-02-14
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of NATCAPSUQ
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-07-20 | July 20, 23 | 1 | 1 | 2023-07-20 | 2023-08-27 | |
| 2022-09-09 | September 09, 22 | 1 | 1 | 2022-09-12 | 2022-10-20 | |
| 2021-07-06 | July 06, 21 | 0.81999 | 0.81999 | 2021-07-07 | 2021-08-14 | |
| 2020-08-12 | August 12, 20 | 0.492 | 0.492 | 2020-08-13 | 2020-09-20 | |
| 2019-08-13 | August 13, 19 | 0.81999 | 0.81999 | 2019-08-14 | 2019-09-21 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 164.15 Cr | 88.43 Cr | 75.73 Cr | 0.4613 | 1.60 Cr | 1.87 Cr | 9.03 Cr | 0.62 Cr | 0.63 | 18.22 Cr | 0.0038 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.66 Cr | 419.35 Cr | 162.19 Cr | 232.9361 Cr | 105.19 Cr | 104.53 Cr | 25.46 Cr | 283.63 Cr | 0.00 Cr | 0.00 Cr | 3.51 Cr | 99.9926 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 26.7521 Cr | -44.4847 Cr | 16.1667 Cr | -17.8781 Cr | -1.5659 Cr | 0.6889 Cr | -44.6302 Cr | 2.7910 Cr | -5.1888 Cr | 0.0000 Cr | -6.4215 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 37.75 Cr | 29.06 Cr | 8.69 Cr | 0.2301 | -6.69 Cr | -7.12 Cr | -6.88 | -2.33 Cr | -0.1886 |
| 2025-09-30 | 45.80 Cr | 24.32 Cr | 21.48 Cr | 0.4691 | -5.17 Cr | -6.99 Cr | -6.76 | -0.72 Cr | -0.1526 |
| 2025-06-30 | 45.20 Cr | 23.57 Cr | 21.63 Cr | 0.4785 | -3.89 Cr | -5.58 Cr | -5.40 | 0.68 Cr | -0.1235 |
| 2025-03-31 | 39.92 Cr | 26.33 Cr | 13.59 Cr | 0.3405 | 2.85 Cr | 0.52 Cr | 0.00 | 4.69 Cr | 0.0130 |
| 2024-12-31 | 43.83 Cr | 22.29 Cr | 21.54 Cr | 0.4915 | 1.93 Cr | 0.11 Cr | 0.10 | 4.38 Cr | 0.0024 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.76 Cr | 4.61 Cr | 5.37 Cr | 62.88 Cr | 25.56 Cr | 131.18 Cr | 282.46 Cr | 419.96 Cr | 174.56 Cr |
| 2025-03-31 | 0.66 Cr | 4.54 Cr | 5.20 Cr | 62.24 Cr | 25.46 Cr | 129.59 Cr | 283.63 Cr | 419.35 Cr | 162.19 Cr |
| 2024-09-30 | 9.45 Cr | 4.61 Cr | 14.06 Cr | 63.10 Cr | 22.09 Cr | 134.94 Cr | 263.55 Cr | 404.66 Cr | 146.32 Cr |
| 2024-03-31 | 1.95 Cr | 11.01 Cr | 12.96 Cr | 54.47 Cr | 19.04 Cr | 123.77 Cr | 246.10 Cr | 376.53 Cr | 147.72 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,764.20 | ₹4,232,906,754,074.00 | ₹1,200,910.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,395.50 | ₹1,697,804,303,390.00 | ₹348,437.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,418.90 | ₹1,495,556,554,816.00 | ₹359,909.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,306.50 | ₹1,087,750,340,235.00 | ₹2,296,180.00 |
| Lupin Limited | LUPIN | ₹2,292.20 | ₹1,047,633,964,600.00 | ₹1,104,211.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹919.65 | ₹925,383,088,904.00 | ₹564,412.00 |
| Mankind Pharma Limited | MANKIND | ₹2,155.70 | ₹889,883,893,710.00 | ₹802,349.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,211.50 | ₹703,641,166,265.00 | ₹3,039,172.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,625.00 | ₹672,553,125,000.00 | ₹231,439.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,085.00 | ₹588,388,686,765.00 | ₹455,450.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,076.35 | ₹581,074,632,036.00 | ₹2,096,370.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,524.50 | ₹386,772,080,341.00 | ₹102,371.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹3,021.30 | ₹377,468,000,791.00 | ₹185,671.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,085.90 | ₹334,844,408,201.00 | ₹172,351.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,430.80 | ₹271,240,390,232.00 | ₹90,076.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,377.10 | ₹223,767,965,930.00 | ₹212,770.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,869.00 | ₹221,725,000,000.00 | ₹2,566.00 |
| Eris Lifesciences Limited | ERIS | ₹1,380.20 | ₹188,006,552,958.00 | ₹30,161.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹978.20 | ₹175,205,274,834.00 | ₹5,721,405.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,331.00 | ₹171,035,250,259.00 | ₹27,190.00 |
| Granules India Limited | GRANULES | ₹599.95 | ₹145,589,096,164.00 | ₹775,187.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹739.90 | ₹145,437,055,448.00 | ₹143,343.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹897.35 | ₹142,113,093,368.00 | ₹305,229.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,727.00 | ₹131,272,198,992.00 | ₹21,410.00 |
| Cohance Lifesciences Limited | COHANCE | ₹310.50 | ₹118,787,096,970.00 | ₹467,931.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.55 | ₹111,389,056,800.00 | ₹41,715.00 |
| Viyash Scientific Limited | VIYASH | ₹219.27 | ₹95,646,792,922.00 | ₹684,479.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,136.00 | ₹85,254,425,952.00 | ₹7,919.00 |
| Strides Pharma Science Limited | STAR | ₹863.60 | ₹79,600,355,810.00 | ₹85,803.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹478.65 | ₹73,282,300,062.00 | ₹136,589.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹708.30 | ₹64,205,475,507.00 | ₹171,833.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹327.45 | ₹64,043,265,649.00 | ₹194,387.00 |
| FDC Limited | FDC | ₹364.30 | ₹59,311,713,601.00 | ₹46,671.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.92 | ₹42,486,366,301.00 | ₹619,172.00 |
| Innova Captab Limited | INNOVACAP | ₹668.35 | ₹38,246,281,297.00 | ₹12,022.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹316.30 | ₹34,465,713,320.00 | ₹32,182.00 |
| Suven Life Sciences Limited | SUVEN | ₹149.76 | ₹34,066,506,240.00 | ₹112,567.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.70 | ₹33,742,519,000.00 | ₹60,664.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹630.60 | ₹31,983,467,613.00 | ₹129,611.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,914.20 | ₹31,658,982,513.00 | ₹9,690.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹279.30 | ₹28,008,903,926.00 | ₹39,032.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1941
Gender: male
Year Born: 1951
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1964
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Natural Capsules Ltd.
The CEO is Sunil Laxminarayana Kumar Mundra.
The current price is ₹155.45.
The range is ₹152-296.
The market capitalization is ₹160.75 crores.
The P/E ratio is -8.39.
The company operates in the Healthcare sector.
Overview of Natural Capsules Ltd. (ISIN: INE936B01015) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹160.75 crores and an average daily volume of 5,355 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.